New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

  Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value of iRhythm’s Zio products and services across a wide range of patient populations

Related Keywords

United States ,Johns Hopkins ,Gaurav Das ,Mike Hsu ,Kevinj Ferrick ,Andrew Krumerman ,Alext Sandhu ,Mintu Turakhia ,Alan Wilk ,Martins Maron ,Mintup Turakhia ,Christopher Madias ,Jayj Chudow ,Lori Crosson ,Krishna Pundi ,Paula Heidenreich ,Barryj Maron ,Ardit Kacorri ,Rhythm Technologies Inc ,Va Health Care System ,Heart Rhythm Society ,University Of Rochester ,Veterans Health Administration ,Rhythm Technologies ,Heart Rhythm ,New Orleans ,Enhances Identification ,Higher Risk Patients With Hypertrophic ,Premature Ventricular Complexes ,Assessing Burden Density ,Large National Cohort Population ,Better Define Optimal ,Practice Variation After Ambulatory ,Non Sustained Ventricular Tachycardia ,Care System ,Randomized Placebo Controlled Trial ,Patients With Arrhythmogenic Right Ventricular ,Ventricular Complexes ,Luigi Di Biase ,Variation After Ambulatory ,Jun Fan ,Natasha Din ,Placebo Controlled Trial ,